Annette H M van der Helm–van Mil

Author

Also Known As

A H M van der Helm - van Mil, A H M van der Helm- van Mil, A H M van der Helm-Van Mil, A H M van der Helm-van Mil, A H van Mil, A H van der Helm-van Mil, A van der Helm-van Mil, A. H. M van der Helm – van Mil, A. H. M van der Helm‐van Mil, A. H. M. van der Helm-van Mil

592

Publications

23.5K

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center Erasmus MC Erasmus University Rotterdam Leiden University Karolinska Institutet

About

Annette H M van der Helm–van Mil is an author at Leiden University Medical Center specializing in medicine, rheumatology, and rheumatoid arthritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	33	3K
2	Health Sciences	7	7	219
3	Engineering	1	1	86
4	Public Health	1	1	246
5	Social Sciences	1	1	55

Annette H M van der Helm–van Mil

222

Publications

17.7K

Citations

H-Index

Page 1

	Year	Citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update Josef S Smolen, Robert Landewé, Sytske Anne Bergstra, Annals of the Rheumatic Diseases	2022	1.6K
Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA–DRB1 shared epitope for antibodies to citrullinated proteins T. Huizinga, Christopher I. Amos, Annette H M van der Helm–van Mil, Arthritis & Rheumatism	2005	585
2016 update of the EULAR recommendations for the management of early arthritis Bernard Combe, Robert Landewé, C. Daïen, Annals of the Rheumatic Diseases	2017	584
Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage Jing Shi, Rachel Knevel, Parawee Suwannalai, Proceedings of the National Academy of Sciences ImmunologyPathologyImmunotherapyInflammationRheumatoid Disorder	2011	554
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis Annette H M van der Helm–van Mil, K. N. Verpoort, Ferdinand C. Breedveld, Arthritis Research & Therapy	2005	474
Long‐term impact of delay in assessment of patients with early arthritis M. P. M. van der Linden, Saskia le Cessie, Karim Raza, Arthritis & Rheumatism	2010	455
Gene-Gene and Gene-Environment Interactions Involving HLA-DRB1, PTPN22, and Smoking in Two Subsets of Rheumatoid Arthritis Henrik Källberg, Leonid Padyukov, Robert M. Plenge, The American Journal of Human Genetics Rheumatoid DisorderRheumatologyAutoimmune DiseaseGeneticsImmunology	2007	452
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis Daniëlle M. Gerlag, Karim Raza, Lisa G. M. van Baarsen, Annals of the Rheumatic Diseases	2012	448
Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes Myles Lewis, Michael R. Barnes, Kevin Blighe, Cell Reports	2019	380
A prediction rule for disease outcome in patients with Recent‐onset undifferentiated arthritis: How to guide individual treatment decisions Annette H M van der Helm–van Mil, Saskia le Cessie, Henrike van Dongen, Arthritis & Rheumatism	2007	365

Page 1